全球家禽疫苗市场规模（依产品类型、疾病类型、剂型、应用、地区、范围和预测）

家禽疫苗市场规模及预测

2024 年家禽疫苗市场规模价值 21.5 亿美元，预计 2032 年将达到 34.2 亿美元，2026 年至 2032 年的复合年增长率为 5.95%。

• 家禽疫苗是保护鸡、火鸡、鸭和其他家禽免受感染疾病的生物製品。
• 疫苗旨在增强鸟类的免疫系统，使它们更能免疫力某些疾病，如病毒和细菌。
• 此外，家禽疫苗可用于预防禽群疾病爆发，改善禽类整体健康状况，降低死亡率，并提高家禽养殖产量。有效的疫苗接种计画还能减少疾病透过食用禽类产品从家禽传播给人类，有助于确保食品安全。

全球家禽疫苗市场动态

关键市场驱动因素

• 禽类疾病和生物安全问题日益令人担忧：新城疫、禽流感和传染性支气管炎病毒 (IBV) 持续对全球家禽业构成挑战，导致禽类死亡、产蛋量下降以及贸易限製造成的经济损失。疫苗接种对于疾病防治至关重要，从而能够提高家禽养殖场的生物安全水平。随着对这些危害及其经济影响的认识不断加深，对有效家禽疫苗的需求也日益增长。
• 禽肉需求成长，禽群规模扩大：禽肉因其价格实惠、健康益处和烹饪多样性，在世界各地越来越受欢迎。这一趋势导致家禽养殖场的禽群规模不断扩大，以满足生产需求。然而，禽群规模越大，疾病传播的风险就越高。在人口密集的地区，接种疫苗对于预防传染病和维护禽群健康至关重要。
• 关注食品安全和公共卫生：消费者重视食品安全，并担心透过家禽产品传播的疾病。家禽疫苗接种计划透过限制通用感染疾病的传播来降低这些风险。健康的家禽群能够稳定地供应安全优质的肉类，而政府为公共卫生和产业生物安全推广疫苗接种的措施也对此提供了支持。

主要挑战

• 疫苗接种失败与低温运输管理：疫苗接种失败的原因多种多样，包括接种技术不当、疫苗储存或运输不当（低温运输中断）以及接种禽类的免疫反应不足。这些失败会导致即使尝试接种疫苗，疾病仍然爆发。解决这些问题并提高疫苗接种效果可能需要确保正确的疫苗接种方法、维护可靠的疫苗储存和运输低温运输，以及生产更具免疫抗原性的疫苗。
• 疫苗接种计画的成本与实施：疫苗接种计画需要在疫苗、设备和训练有素的人员方面进行投资。这给家禽养殖户，尤其是小规模养殖户带来了经济负担。此外，在大型农场实施高效率的疫苗接种计画需要周详的规划、物流和生物安全预防措施。开发经济有效的疫苗接种方法、为养殖户提供培训和技术援助以及简化疫苗接种程序，都有助于克服这些挑战并提高疫苗接种覆盖率。

主要趋势：

• 重组疫苗和载体疫苗的开发：传统家禽疫苗使用灭活病原体，重组疫苗利用特定基因触发免疫反应，载体疫苗则利用无害病毒递送保护性抗原。这些现代方法有望为鸡群提供更广泛的保护，提高安全性并提升疫苗接种的生产效率。
• 卵内免疫接种及自动化重点：卵内免疫接种是指将疫苗注射到胚胎蛋中，比传统技术更早保护鸡隻，并产生更好的免疫反应。自动化，包括自动化疫苗接种设备和数据系统，旨在简化流程，最大限度地降低人事费用，并确保所有家禽农场的疫苗接种准确一致。
• 多重药物免疫计画和疫苗接种监测的兴起：多重药物免疫计画使用多种疫苗来对抗新兴疾病并改善鸡群健康。借助先进的监测工具，农民可以即时评估疫苗接种覆盖率、抗体水平和疾病发生情况，从而优化疫苗接种策略并加强整体禽类健康管理。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 家禽疫苗市场（依产品类型）

• 改良或减毒（活病毒疫苗）
• 灭活（杀死）
• 重组疫苗

5. 家禽疫苗市场（依疾病类型）

• 新城疫
• 马立克氏症
• 传染性支气管炎
• 传染性黏液囊炎
• 其他的

6. 家禽疫苗市场（按剂型）

• 液体疫苗
• 冻干疫苗
• 管

6. 家禽疫苗市场（依应用）

• 饲养员
• 肉鸡
• 图层

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Ceva Sante Animale
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Venkys India Limited
• Phibro Animal Health Corporation
• Huvepharma AD
• Dechra Pharmaceuticals PLC

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Poultry Vaccines Market Size and Forecast

Poultry Vaccines Market size was valued at USD 2.15 Billion in 2024 and is projected to reach USD 3.42 Billion by 2032, growing at a CAGR of 5.95% from 2026 to 2032.

• Poultry vaccines are biological products that protect chickens, turkeys, ducks, and other poultry animals from infectious illnesses.
• The vaccines are designed to boost the immune system of birds, allowing them to build immunity to specific diseases such as viruses and bacteria.
• Furthermore, poultry vaccines are used to prevent disease outbreaks within flocks, improving general bird health, lowering mortality rates, and increasing production in the poultry business. Effective vaccination programs also help to ensure food safety by reducing the spread of diseases from poultry to humans through the consumption of chicken products.

Global Poultry Vaccines Market Dynamics

The key market dynamics that are shaping the poultry vaccines market include:

Key Market Drivers

• Rising Concerns About Avian Diseases and Biosecurity: Newcastle disease, Avian Influenza (bird flu), and Infectious Bronchitis Virus (IBV) continue to pose challenges to the worldwide poultry sector, resulting in economic losses due to bird death, lower egg production, and trade restrictions. Vaccination is critical for disease prevention and management, which improves biosecurity on chicken farms. Growing knowledge of these hazards and their economic consequences fuels the demand for effective poultry vaccines.
• Increasing Demand for Poultry Meat and Growing Flock Sizes: Poultry meat is becoming more popular worldwide due to its affordability, health benefits, and culinary variety. This trend leads to increased flock sizes on chicken farms to fulfill production demands. However, larger flocks increase the likelihood of disease transmission. Vaccination becomes critical in densely populated areas to avoid epidemics and keep flocks healthy.
• Focus on Food Safety and Public Health: Consumers value food safety and are concerned about diseases spread through poultry products. Poultry vaccination programs reduce these hazards by limiting the transmission of zoonotic illnesses, which are transmissible from animals to people. Healthy poultry flocks maintain a steady supply of safe, high-quality meat, which is aided by government initiatives to promote vaccination for public health and industry biosecurity.

Key Challenges:

• Vaccination Failures and Cold Chain Management: Vaccination failures occur for a variety of reasons, including ineffective administration techniques, wrong vaccine storage or transportation (breaking the cold chain), or insufficient immunological response in vaccinated birds. Regardless of immunization attempts, these failures result in disease outbreaks. Addressing this difficulty and improving vaccination efficacy can be accomplished by ensuring adequate vaccination practices, maintaining a dependable cold chain for vaccine storage and shipping, and potentially producing stronger immunogenic vaccines.
• Cost Considerations and Vaccination Program Implementation: Vaccination programs necessitate investments in vaccines, equipment, and trained workers. This is a financial strain for some poultry farmers, especially those operating on a small scale. Also, executing efficient immunization programs on big chicken farms necessitates careful planning, logistics, and biosecurity precautions. Developing cost-effective vaccination options, providing farmers with training and technical support, and streamlining vaccination procedures all contribute to overcoming these difficulties and increasing vaccination practice uptake.

Key Trends:

• Development of Recombinant Vaccines and Vector Vaccines: Traditional poultry vaccines use inactivated pathogens, while recombinant vaccines use particular genes to trigger an immune response, and vector vaccines use harmless viruses to deliver protective antigens. These modern methods provide broader protection, may improve safety, and increase production efficiency in chicken vaccination.
• Focus on In-ovo Vaccination and Automation: In-ovo vaccination involves injecting vaccines into embryonated eggs, resulting in earlier chick protection and better immune responses than traditional techniques. Automation, which includes automated vaccination devices and data systems, is intended to streamline procedures, minimize labor costs, and assure exact and consistent immunization throughout poultry farms.
• Rise of Multimodal Vaccination Programs and Vaccination Monitoring: Multimodal vaccination programs use various vaccines to battle emerging diseases and improve flock health. Farmers may optimize vaccination tactics and enhance overall chicken health management by using advanced monitoring tools to assess vaccination coverage, antibody levels, and disease outbreaks in real-time.

Global Poultry Vaccines Market Regional Analysis

Here is a more detailed regional analysis of the poultry vaccines market:

Asia Pacific:

• According to Verified Market Research, the Asia Pacific region is estimated to dominate the poultry vaccines market over the forecast period. The Asia-Pacific region has the world's largest poultry production sector, with China dominating both production and consumption of poultry meat. A flourishing chicken business requires a strong market for poultry vaccinations to protect flock health, improve biosecurity measures, and meet rising demand for safe poultry products.
• Governments around the Asia Pacific are becoming more aware of the economic and public health dangers posed by avian illnesses. Poultry farmers have become more conscious of the importance of vaccination programs for disease prevention and management. Government initiatives such as vaccine subsidies and planned vaccination campaigns help to boost market expansion.
• Furthermore, many of Asia Pacific's small and medium-sized chicken farms demand low-cost immunization alternatives. Vaccine makers in the region are reacting by developing cost-effective poultry vaccinations customized to local demands. Local production capabilities reduce reliance on imports, providing timely delivery and excellent cold chain management to keep vaccines effective.

North America:

• North America is estimated to exhibit substantial growth during the forecast period. North American chicken breeders follow strict biosecurity regulations and disease control procedures. Mandatory vaccination programs for certain chicken diseases are enforced, resulting in extensive vaccine use. The emphasis on biosecurity standards within the industry emphasizes preventive measures such as vaccination to reduce outbreak risks and maintain chicken flock health.
• North America leads in animal health research, which drives ongoing innovation in poultry vaccinations. Manufacturers are exploring recombinant vaccines, vector vaccines, and in-ovo immunization technologies to improve efficacy and convenience of delivery. These innovations enhance disease control capacities, hence improving overall poultry health management in the region.
• Furthermore, the North American poultry industry is progressively adopting precision livestock farming (PLF) technologies. PLF optimizes production through the use of sensors, analytics, and automation. Immunization programs connected with PLF systems allow for real-time monitoring of immunization status, bird health, and illness identification. This data-driven method improves vaccination effectiveness and disease management on poultry farms in North America.

Europe:

• European countries encourage preventative healthcare in animal husbandry, stressing immunization to limit disease transmission and dependency on medications. Stringent laws prohibit the use of antibiotics as growth boosters, emphasizing vaccines as the major strategy for keeping chickens healthy.
• European consumers are increasingly concerned with food safety and sustainability. Poultry vaccination programs reduce disease transmission, resulting in safe and reliable poultry products. Vaccination supports sustainable farming techniques by improving animal welfare and minimizing the environmental impact of antibiotic use.
• Furthermore, Europe is a leader in animal health research, which drives innovation in poultry vaccines. Advanced vaccines are effective against a wide range of diseases. Strict EU biosecurity laws require excellent cleanliness standards and disease control methods on chicken farms, with vaccination playing an important part in compliance and farm biosecurity.

Global Poultry Vaccines Market: Segmentation Analysis

The Poultry Vaccines Market is segmented based on Product Type, Disease Type, Dosage Form, Application, and Geography.

Poultry Vaccines Market, By Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

Based on the Product Type, the market is segmented into Modified or Attenuated, Inactivated, and Recombinants. The inactivated segment is estimated to dominate the poultry vaccines market due to their safety, acceptability for birds of all ages, and efficacy against a variety of poultry diseases. They benefit from existing production processes, possible cost savings, and regulatory acceptance based on their demonstrated efficacy and safety profile in preventing chicken illnesses.

Poultry Vaccines Market, By Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

Based on the Disease Type, the market is segmented into Newcastle Disease, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease, and Others. The Newcastle disease segment is estimated to dominate the poultry vaccines market during the forecast period due to its highly contagious nature and destructive impact on poultry. This avian paramyxovirus causes significant economic losses due to high mortality rates, reduced egg output, and probable trade restrictions. Many countries require ND vaccination to prevent its spread and protect poultry industries, as it is recognized as a concern worldwide. Continuous vaccination efforts against various strains of ND strengthen its market position.

Poultry Vaccines Market, By Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

Based on the Dosage Form, the market is segmented into Liquid Vaccine, Freeze Dried Vaccine, and Duct. The liquid vaccine segment is estimated to exhibit the highest growth within the poultry vaccines market owing to its ease of administration by drinking water, eye drops, or spray methods. This convenience makes liquid vaccinations ideal for bulk vaccination in large-scale chicken farms. Furthermore, their lower production costs compared to freeze-dried vaccines make them appealing to poultry farmers, particularly in areas with a high concentration of small to medium-sized enterprises. Liquid vaccines are especially well suited for broiler applications, where their rapid immune response matches the demands of shorter production cycles.

Poultry Vaccines Market, By Application

• Breeder
• Broiler
• Layer

Based on Application, the market is segmented into Breeder, Broiler, and Layer. The broiler segment is estimated to dominate the poultry vaccines market. Broiler chickens reared for meat have a limited lifespan and are housed in high densities, which increases disease transmission risks. Vaccination is critical in these situations to avoid epidemics and keep flocks healthy. Given the economic importance of the broiler business and its huge worldwide production volumes, effective vaccination programs are critical to reducing economic losses from disease outbreaks and assuring a steady supply of poultry meat.

Poultry Vaccines Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Poultry Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. According to the VMR analyst, Asia Pacific is estimated to dominate during the forecasted period. The Asia Pacific region, led by major chicken producers such as China, is experiencing tremendous growth in the poultry business. This spike emphasizes the need for a strong poultry vaccine market to protect flock health and meet the growing demand for safe chicken products. Governments are actively pushing vaccination programs, financing vaccinations, and encouraging local production to ensure cost-effective solutions and disease control across a wide range of chicken farming environments.

Key Players

• The "Poultry Vaccines Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boehringer Ingelheim International GmbH, Zoetis, Inc., Ceva Sante Animale, Merck & Co., Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Venkys India Limited, Phibro Animal Health Corporation, Huvepharma AD, and Dechra Pharmaceuticals PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Poultry Vaccines Market Recent Developments
• In August 2022, Bimeda, an Ireland-based company specializing in veterinary medications and animal care products, purchased Afrivet for an unknown amount. With this acquisition, Bimeda will have the largest animal health company presence in Africa. Afrivet is a South African manufacturer of chicken vaccinations.
• In December 2021, Immuno-intelligent Limited, an Indian antibody maker, introduced a new goat pox vaccine to prevent disease. At 90 days old, a live, weakened antibody should be administered subcutaneously at a rate of 1 ml.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Poultry Vaccines Market, By Product Type

• Modified or Attenuated (Live)
• Inactivated (Killed)
• Recombinants

5. Poultry Vaccines Market, By Disease Type

• Newcastle Disease
• Marek's Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

6. Poultry Vaccines Market, By Dosage Form

• Liquid Vaccine
• Freeze Dried Vaccine
• Duct

6. Poultry Vaccines Market, By Application

• Breeder
• Broiler
• Layer

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Boehringer Ingelheim International GmbH
• Zoetis Inc.
• Ceva Sante Animale
• Merck & Co., Inc.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Venkys India Limited
• Phibro Animal Health Corporation
• Huvepharma AD
• Dechra Pharmaceuticals PLC

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References